PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.

Published in: Tobacco control (2018)

Despite delivering lower levels of some toxins than conventional cigarettes, PMI's own data fail to show consistently lower risks of harm in humans using its heated tobacco product, IQOS, than conventional cigarettes.

Keyphrases

smoking cessation
electronic health record
replacement therapy
big data
human health
risk assessment
machine learning
artificial intelligence